Eutropics Pharmaceuticals, Inc.
Pharmaceutical company · Cambridge, Massachusetts, United States
Eutropics Pharmaceuticals, Inc. is a pharmaceutical company headquartered in Cambridge, Massachusetts, United States. It has received 7 US government small-business research awards (SBIR/STTR) from health agencies, $8.1 million in total, most recently in 2017. It has reported private securities offerings to the US SEC, most recently $350,000 sold in a notice filed in 2021.
Eutropics Pharmaceuticals at a glance
What does Eutropics Pharmaceuticals do?
US government research funding
7 SBIR/STTR small-business research awards from US health agencies, $8.1 million in total (2008 to 2017). NIH funding came from the National Cancer Institute.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $350,000 sold (2021).
Frequently asked questions about Eutropics Pharmaceuticals
Where is Eutropics Pharmaceuticals headquartered?
Eutropics Pharmaceuticals, Inc. is headquartered in Cambridge, Massachusetts, United States.
What does Eutropics Pharmaceuticals do?
Eutropics Pharmaceuticals, Inc. is a pharmaceutical company.
Similar companies
- Spero Therapeutics, Inc.Cambridge, Massachusetts, United States
- Sarepta Therapeutics, Inc.Cambridge, Massachusetts, United States
- Alnylam Pharmaceuticals, Inc.Cambridge, Massachusetts, United States
- Visterra, Inc.Cambridge, Massachusetts, United States
- Seres Therapeutics, Inc.Cambridge, Massachusetts, United States
- Merrimack Pharmaceuticals IncCambridge, Massachusetts, United States
- QurAlis CorpCambridge, Massachusetts, United States
- Apnimed, Inc.Cambridge, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences